PEPTIDEREPORT

Peer reviewed

Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases

Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases

PubMed / NCBIAccessed Aug 2, 2026

Open original source

Registry record

Source metadata

Publisher
PubMed / NCBI
Source type
Peer reviewed
Registry ID
pubmed-fisetin-senotherapeutic-review-2024
PMID
39384074

Source usage

Linked from 2 pages

Compound

Fisetin

Guide

Peptide Half-Life Reference Table

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.